SCHEMBL29618249

SCHEMBL29618249

COc1cccc2c1N=C(c1ncccc1C(N)=O)N1CCN=C21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTAFR P25105 2/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 3/20 0.37
HSD17B10 Q99714 2/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
PARP1 P09874 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
USP2 O75604 1/20 0.35
TSHR P16473 3/20 0.35
HPGD P15428 1/20 0.35
GPR52 Q9Y2T5 2/20 0.34
UGCG Q16739 2/20 0.34
GFER P55789 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4538684 0.85 KDM4E (0.34) PTAFRKDM4EGPR52
SCHEMBL4537899 0.78 PIK3CB (0.43)
SCHEMBL4543548 0.78 PIK3CB (0.44)
SCHEMBL4541825 0.77 PIK3CB (0.43)
SCHEMBL86828 0.77 KMT2A (0.40) KDM4EALDH1A1HSD17B10CYP2C9CYP2C19
SCHEMBL4533432 0.76 PIK3CB (0.44) PARP1
SCHEMBL29475045 0.76 PIK3CB (0.44) PARP1
SCHEMBL4529997 0.76 PIK3CB (0.44) PARP1
SCHEMBL4542555 0.76 PIK3CB (0.44) PARP1
SCHEMBL4533089 0.76 PIK3CB (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115724847-A 2, 3-dihydroimidazo [1,2-c ] quinazoline substituted derivatives 拜耳知识产权有限责任公司 2023-03-03 CN disclosed
CN-108774232-B 2, 3-dihydroimidazo [1,2-c ] quinazoline substituted derivatives 拜耳知识产权有限责任公司 2022-08-09 CN disclosed
CN-105254634-B 2, 3-dihydroimidazo [1,2-c ] quinazoline substituted derivatives useful in the treatment of hyperproliferative diseases and angiogenesis-related diseases 拜耳知识产权有限责任公司 2022-05-27 CN disclosed